KATHLEEN HANLEY: Open Payments
NPI 1609061258 · LEE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 14 payments from 7 companies in 2025. Trend: 2023 $188 · 2024 $450 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $125 |
| UCB, Inc. | 1 | $122 |
| Lilly USA, LLC | 4 | $120 |
| Alexion Pharmaceuticals, Inc. | 1 | $106 |
| Novartis Pharmaceuticals Corporation | 4 | $94 |
| ABBVIE INC. | 2 | $40 |
| ARGENX US, INC. | 1 | $25 |
Products named: Leqembi, Rystiggo, KESIMPTA, KISUNLA, UBRELVY, VYVGART HYTRULO, EMGALITY, AMYVID.
Industry payments across MA — which companies pay providers there.
